IP Library › Granted Patent US 12,224,050
Granted Patent B2
US 12,224,050 · App. 16/760,026 · Granted Feb 11, 2025

Control of medical device using wireless communication

Inventors: Christian Peter Enggaard (Vejby, DK); Rune Ravn (Hasaselager, DK)
Assignee: Novo Nordisk A/S.
G16H20/17A61M5/31535A61M5/31546A61M5/3159G16H40/67A61M2005/3125A61M5/31571A61M5/31573A61M2205/18A61M2205/3553A61M2205/50A61M2205/581A61M2205/582A61M2205/583
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,224,050
App. No.
16/760,026
Granted
Feb 11, 2025
Kind
B2
Abstract

The present invention provides a system ( 1 ) comprising: a pen injection device ( 10 ) holding a specific type of medicament and comprising a dose expelling mechanism and pen communication means ( 15 ), a mobile communication unit ( 30 ) comprising mobile communication means ( 35 ) adapted to communicate with the pen communication means ( 15 ), and a software application program configured to determine a recommended type of medicament to be delivered to a user based on information indicative of a physiological condition of the user, wherein the pen injection device ( 10 ) further comprises indication means which in a first state indicates that the dose expelling mechanism is to remain idle and in a second state indicates that the dose expelling mechanism is available for operation, and wherein the mobile communication unit ( 30 ) is configured to, via a communication from the mobile communication means ( 35 ) to the pen communication means ( 15 ), a) prompt a change of state of the indication means from the second state to the first state in response to the recommended type of medicament to be delivered differing from the specific type of medicament, and/or b) prompt a change of state of the indication means from the first state to the second state in response to the recommended type of medicament to be delivered corresponding to the specific type of medicament.

Claims (26)

1. A pen injection safety system having two-way communication between a mobile communication unit and at least two pen injection devices, the system comprising:

a first pen injection device holding a first specific type of medicament and comprising:

a first dose expelling mechanism,

a first pen communication structure, and

a first indication structure which in a first state indicates that the first dose expelling mechanism is to remain idle and in a second state indicates that the first dose expelling mechanism is available for operation,

a second pen injection device holding a second specific type of medicament and comprising:

a second dose expelling mechanism,

a second pen communication structure, and

a second indication structure which in a first state indicates that the second dose expelling mechanism is to remain idle and in a second state indicates that the second dose expelling mechanism is available for operation,

the mobile communication unit comprising mobile communication structure adapted for two-way communication with each of the first pen communication structure and the second pen communication structure, and

a software application program configured to determine a recommended type of medicament to be delivered to a user as one of the first specific type of medicament and the second specific type of medicament based on information indicative of a physiological condition of the user,

wherein the mobile communication unit is configured to, via a communication from the mobile communication structure to at least one of the first pen communication structure and the second pen communication structure,

prompt a change of state of the first indication structure from the second state to the first state and/or a change of state of the second indication structure from the first state to the second state in response to the recommended type of medicament to be delivered being the second specific type of medicament, and

prompt a change of state of the second indication structure from the second state to the first state and/or a change of state of the first indication structure from the first state to the second state in response to the recommended type of medicament to be delivered being the first specific type of medicament,

thereby providing a pen injection safety system reducing the risk of the user inadvertently administering medicament which differs from the recommended type of medicament.

2. The pen injection safety system according to claim 1 , wherein the software application program is configured to determine the recommended type of medicament to be delivered based at least in part on information sent from the first pen communication structure to the mobile communication structure.

3. The pen injection safety system according to claim 1 , wherein the first pen injection device further comprises a dose setting mechanism operable to set a dose to be delivered.

4. The pen injection safety system according to claim 3 , wherein prompting a change of state of the first indication structure from the second state to the first state comprises disabling the dose setting mechanism.

5. The pen injection safety system according to claim 3 , wherein the first pen injection device further comprises a dose display for visual confirmation of a set dose, and wherein prompting the change of state of the first indication structure from the second state to the first state comprises affecting the dose display.

6. The pen injection safety system according to claim 3 , wherein the mobile communication unit further comprises an alert generator adapted emit an alert signal, wherein the first pen communication structure is configured to register and to notify the mobile communication structure of an ongoing operation of the dose setting mechanism, and wherein the alert generator is configured to emit the alert signal, if the mobile communication structure receives a notification from the first pen communication structure and the recommended type of medicament is the second specific type of medicament.

7. The pen injection safety system according to claim 1 , wherein the first pen injection device further comprises a sound generator, and wherein prompting the change of state of the first indication structure from the second state to the first state comprises producing a notifying sound via the sound generator.

8. The pen injection safety system according to claim 1 , wherein prompting the change of state of the first indication structure from the second state to the first state comprises disabling the first dose expelling mechanism.

9. The pen injection safety system according to claim 1 , wherein the mobile communication unit further comprises an alert generator adapted emit an alert signal, wherein the first pen communication structure is configured to register and to notify the mobile communication structure of an ongoing operation of the first dose expelling mechanism, and wherein the alert generator is configured to emit the alert signal, if the mobile communication structure receives a notification from the first pen communication structure and the recommended type of medicament is the second specific type of medicament.

10. The pen injection safety system according to claim 1 , wherein the recommended type of medicament is selected from a group consisting of a) a first type of diabetes medication and b) a second type of diabetes medication.

11. The pen injection safety system according to claim 10 , wherein the first type of diabetes medication is a rapid acting insulin and the second type of diabetes medication is a long acting insulin.

12. The pen injection safety system according to claim 1 , wherein prompting a change of state of the first indication structure from the first state to the second state comprises providing a visual, audible and/or tactile signal that the first pen injection device is ready to be used.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2020
From: ENGGAARD, CHRISTIAN PETER; RAVN, RUNE
To: NOVO NORDISK A/S
Reel/Frame 053757/0716 →
Priority Claims (1)
EP 17199399 · Oct 31, 2017 · regional
Continuity (1)
Related Publication 20200294646A1 · Sep 17, 2020
References Cited (27)
US 6010492A · Jacobsen et al. · 2000 [cited by applicant]
US 9672328B2 · Saint et al. · 2017 [cited by applicant]
US 10252002B2 · Haider et al. · 2019 [cited by applicant]
US 10391235B2 · Schabbach et al. · 2019 [cited by applicant]
US 20070078818A1 · Zivitz et al. · 2007 [cited by applicant]
US 20080300534A1 · Blomquist · 2008 [cited by examiner]
US 20100016700A1 · Sieh et al. · 2010 [cited by applicant]
US 20130245545A1 · Arnold et al. · 2013 [cited by applicant]
US 20140324020A1 · Stefansen · 2014 [cited by applicant]
US 20160012205A1 · Saint · 2016 [cited by examiner]
US 20160030683A1 · Taylor et al. · 2016 [cited by applicant]
US 20170098058A1 · McCullough et al. · 2017 [cited by applicant]
US 20170106052A1 · Spat et al. · 2017 [cited by applicant]
US 20170274149A1 · Aeschlimann · 2017 [cited by applicant]
US 20170338864A1 · Rolsted et al. · 2017 [cited by applicant]
CN 102548467A · 2012 [cited by applicant]
CN 103874459A · 2014 [cited by applicant]
CN 107073207A · 2017 [cited by applicant]
CN 107073213A · 2017 [cited by applicant]
CN 107106784A · 2017 [cited by applicant]
EP 3042676A1 · 2016 [cited by applicant]
JP 2007267870A · 2007 [cited by applicant]
JP 2013521963A · 2013 [cited by applicant]
WO 2010098929A1 · 2010 [cited by applicant]
WO 2010128493A2 · 2010 [cited by applicant]
WO 2015047870A1 · 2015 [cited by applicant]
WO 2016120207 · 2016 [cited by applicant]